Systemic inflammation and survival of patients with prostate cancer: evidence from the Glasgow Inflammation Outcome Study

Discovering Disease-specific Biomarker Genes for Cancer Diagnosis and Prognosis

(2014) Hung-Chung Huang et al.   TECHNOLOGY IN CANCER RESEARCH & TREATMENT

An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study

(2011) M J Proctor et al.   BRITISH JOURNAL OF CANCER

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study

(2010) M J Proctor et al.   BRITISH JOURNAL OF CANCER

Prostate cancer incidence and mortality trends in 37 European countries: An overview

(2010) F. Bray et al.   EUROPEAN JOURNAL OF CANCER

Estimates of cancer incidence and mortality in Europe in 2008

(2010) J. Ferlay et al.   EUROPEAN JOURNAL OF CANCER

Systemic Inflammatory Response and Survival in Patients with Localised Prostate Cancer: 10-Year Follow-Up

(2010) Peter A. McArdle et al.   UROLOGIA INTERNATIONALIS

Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability

(2009) F. Colotta et al.   CARCINOGENESIS

Role of systemic inflammatory response in predicting survival in patients with primary operable cancer

(2009) Campbell SD Roxburgh et al.   Future Oncology

Elevated Biomarkers of Inflammation Are Associated With Reduced Survival Among Breast Cancer Patients

(2009) Brandon L. Pierce et al.   JOURNAL OF CLINICAL ONCOLOGY

C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis

(2009)   LANCET

Inflammation and prostate cancer

(2008) Sonya Vasto et al.   Future Oncology

Prostate-cancer mortality in the USA and UK in 1975–2004: an ecological study

(2008) Simon M Collin et al.   LANCET ONCOLOGY

Preoperative Neutrophil-to-Lymphocyte Ratio as a Prognostic Predictor after Curative Resection for Hepatocellular Carcinoma

(2008) D. Gomez et al.   WORLD JOURNAL OF SURGERY